Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Glucagon-like peptide 1 and fibroblast growth factor-21 in non-alcoholic steatohepatitis: An experimental to clinical perspective — Poonam Yadav (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Glucagon-like peptide 1 and fibroblast growth factor-21 in non-alcoholic steatohepatitis: An experimental to clinical perspective
RW
Shared by
Ralf Weiskirchen
Glucagon-like peptide 1 and fibroblast growth factor-21 in non-alcoholic steatohepatitis: An experimental to clinical perspective
Article
2022
en
Authors
+2 more
PY
Poonam Yadav
AK
Amit Khurana
JB
Jasvinder Singh Bhatti
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
Masatoshi Kudo
Article
2014
Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model
Sandra Winkler
,
Erawan Borkham‐Kamphorst
,
Peggy Stock
,
S Brückner
,
Matthias Dollinger
,
Ralf Weiskirchen
,
Bruno Christ
Letter
2021
Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinoma
Masatoshi Kudo
Article
2025
Glucagon-like peptide-1 receptor agonists associated with improved clinical outcomes in patients with inflammatory bowel disease: a retrospective cohort study
Feyzullah Aksan
,
Alan Abboud
,
Lokman Hekim Tanrıverdi
,
Olga C. Aroniadis
,
Farah Monzur
Article
1993
Cultured human airway epithelial cells release fibroblast mitogens: a role for insulin-like growth factor 1 (IGF-1)
A.D. Cambrey
,
Ok-Seon Kwon
,
Robin J. McAnulty
,
N. K. Harrison
,
Peter J Barnes
,
Laurent Guy
,
Kian Fan Chung
Discussion(0)
No comments yet. Be the first to comment.